Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Open-market sale EVP, Europe Commercial sold 45,003 shares at an average $42.86 ($1,928,944)
  2. 4 Planned sale President and CEO sold 250,000 shares at $42.24 ($10,559,175)
  3. 4 Open-market sale See "Remarks" sold 44,710 shares at $44.14 ($1,973,544)
  4. 4 Open-market sale Chief Accounting Officer sold 17,289 shares at an average $43.04 ($744,049)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale See "Remarks" sold 46,000 shares at $41.93 ($1,928,729)
  9. 4 Open-market sale Interim Cheif Legal Officer sold 26,260 shares at $41.72 ($1,095,567)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Interim Chief Legal Officer sold 7,342 shares at an average $38.85 ($285,215)
  12. 4 Open-market sale Director sold 367,600 shares at $39.06 ($14,356,802)
  13. 4 Open-market sale Chief Accounting Officer sold 9,445 shares at an average $37.62 ($355,301)
  14. 4 Open-market sale Director sold 415 shares at $37.25 ($15,459)
  15. 4 Planned sale EVP, Business Development sold 18,600 shares at $36.57 ($680,291)
  16. 4 Open-market sale Director sold 17 shares at $34.87 ($593)
  17. 4 Planned sale See "Remarks" sold 12,827 shares at $34.88 ($447,351)
  18. 4 Planned sale See "Remarks" sold 25,578 shares at $34.88 ($892,051)
  19. 4 Open-market sale EVP, Global Operations sold 9,989 shares at $32.19 ($321,547)
  20. 4 Planned sale EVP, Chief Financial Officer sold 106,563 shares at $34.10 ($3,633,308)

Page 1 of 34 · 665 filings